Low-molecular-weight heparins (LMWH) are a class of drugs used for treatment of patients with thrombosis, or blood clots, and as prophylaxis for those who are at risk of thrombosis. They are injectable drugs, usually given sub-cutaneously. Enoxaparin, dalteparin and nadroparin are all examples...
戊戌数据药品标准数据库提供了Low-molecular-weight Heparins马丁代尔药物大典标准的查询检索,包括Low-molecular-weight Heparins马丁代尔药物大典的版本Martindale38th页码,以及药典的查询与下载.
国家药品标准物质使用说明书 低分子量肝素 Low molecular weight heparin 【类别】 标准品 【批号】 140647-201602 【结构式】 / 【分子式】 / 【分子量】 / 【CAS 号】 9041-08-1 【用途】 供低分子量肝素抗 Xa 因子和抗 IIa 因子效价测定用.本品 抗 Xa 因子效价为 1497 IU/安瓿,抗 IIa 因子效价为...
Low molecular weight heparins (LMWHs) are mixtures of heparin molecules in the range of 3000 to 10,000 daltons. As LMWHs of various manufacturers are all produced differently, they are not comparable to each other and are therefore considered to be individual products with different pharmacologic...
平台编号:140647 CAS.NO:批号140647-201602 浓度/规格:约10mg/支;供效价测定用;-20℃,避光 是否有货:有货 购买数量: -1+ 注意事项:本网站销售的所有产品仅用于工业应用或者科学研究等,不可用于人类或动物的临床诊断或治疗,非药用,非食用。 详细信息 ...
bLow-Molecular-Weight Heparins LMWHcan be administered SC once or twice daily without laboratory monitoring in the majority of patients. However, in certain clinical situations, such assevere renal failureor pregnancy, dose adjustment might be required, and if so, can be achieved by monitoring plas...
英文别名: LowMolecularWeightHeparin(Lmwh)中文名: 中文别名: CBNumber: CB11026651 分子式: 分子量: 0 MOL File: Mol file 化学性质 安全信息 用途 供应商 2 LowMolecularWeightHeparin(Lmwh)化学性质 安全信息LowMolecularWeightHeparin(Lmwh)性质、用途与生产工艺 LowMolecularWeightHeparin(Lmwh) 上下游产品信息 ...
低分子量肝素钙注射液药品报告提供了低分子量肝素钙注射液的各种信息,包括低分子量肝素钙注射液的药品简介,新药研发进度,仿制药申报进度,中国药品注册情况,一致性评价进度,药品临床试验进度,药品上市等信息.更多药物报告的查询就在戊戌数据药物报告数据库.
Low-molecular-weight heparins (LMWHs), for example, dalteparin, enoxaparin, among others, are anticoagulants. These drugs are used in the prophylaxis of venous thromboembolic disease (VTE) on acute or elective admission to the hospital, and they are used in the treatment of deep vein thromboses...
Low-molecular-weight heparins (LMWH) are a new group of parenteral anticoagulants that represent a major clinical advance in anticoagulation since the identification of unfractionated heparin (UFH) in 1922 and the introduction of the synthetic coumarin derivative, warfarin, in 1948. 55 Their predictabl...